Investor Relations News
-
RENOVO GROUP PLC (“Renovo” or “the Company”) AGM STATEMENT AND BOARD CHANGES Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring at multiple... en lire plus
-
INTERIM MANAGEMENT STATEMENT Ahead of its Annual General Meeting to be held at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE on 20 February 2008, Renovo Gr... en lire plus
-
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Renovo Group plc 2.... en lire plus
-
RENOVO GROUP PLC PRESENTATION AT THE 26THANNUAL JPMORGAN HEALTHCARE CONFERENCE... en lire plus
-
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:... en lire plus